Using a Fan With Aromatherapy in Breathlessness Patients in Terminal Illness

The Effect of Using a Fan With Aromatherapy in Breathlessness Patient in Terminally Illness: a Randomized Control Trial

Difficulty breathing is a very devastating symptom, often seen in terminal patients. Accompanied by physical, psychological, emotional, and social limitations, Not to mention the ambiguity in the occurrence of dyspnea symptoms and the difficulty in obtaining satisfactory quality of symptom care. The purpose of this study is to confirm the use of non-drug interventions in clinical situations, such as fans and aromatherapy to alleviate the complications of end-stage patients. The effectiveness of the symptoms of dyspnea.

Difficulty breathing is a very devastating symptom, often seen in terminal patients. Accompanied by physical, psychological, emotional, and social limitations, Not to mention the ambiguity in the occurrence of dyspnea symptoms and the difficulty in obtaining satisfactory quality of symptom care. The purpose of this study is to confirm the use of non-drug interventions in clinical situations, such as fans and aromatherapy to alleviate the complications of end-stage patients. The effectiveness of the symptoms of dyspnea.

Inclusion criteria

1. Over 20 years old.
2. It is determined by the physician to meet the final diagnosis conditions.
3. Symptoms of dyspnea.
4. The daily physical status of patients is assessed using the East Coast Cancer Clinical Research Cooperative Organization Assessment Scale (Eastern Cooperative Oncology Group, ECOG) ≧ 2 points.
5. Able to communicate in Mandarin or Taiwanese or written conversation.
6. Unconscious disorder.
7. After explaining and explaining, agree to participate in this research and sign the consent form.

Exclusion criteria

1. Receive treatment for facial trigeminal nerve damage.
2. Abnormal sense of smell.

Inclusion Criteria:

1. Over 20 years old.
2. It is determined by the physician to meet the final diagnosis conditions.
3. Symptoms of dyspnea.
4. The status of patients is assessed using the East Coast Cancer Clinical Research Cooperative Organization Assessment Scale (ECOG) ≧ 2 points.
5. Able to communicate in Mandarin or Taiwanese or written conversation.
6. Conscience clear.
7. After explaining and explaining, agree to participate in this research and sign the consent form.

Exclusion Criteria:

1. Receive treatment for facial trigeminal nerve damage.
2. Abnormal sense of smell.